Superficial vaginal fibroblastoma (SCVM), a rare benign mesenchymal tumor, is notoriously challenging to diagnose due to its asymptomatic presentation and location. Typically seen on ultrasound as a well-defined, homogeneous, medium-echogenic mass with abundant vascularity, it is often missed by conventional transvaginal ultrasound (TVUS) with end-fire probes, which inadequately assess the vaginal canal. To address this, we employed a novel integrated approach using transrectal biplane ultrasound (TRBU) and contrast-enhanced ultrasound (CEUS). This strategy significantly advances the early and accurate diagnosis of vaginal fibromas.
A 54-year-old female with no obvious symptoms presented for evaluation of a vaginal wall mass detected during a routine physical examination.
TRBU revealed a 30 mm-diameter hypoechoic mass on the left vaginal wall. CEUS demonstrated a hyperperfused mass with a capsular appearance, which was presumed to be benign. The patient’s HPV test was negative, and laboratory investigations showed tumor markers within normal ranges.
The patient underwent vaginal lesion resection, which was confirmed histopathologically as a vaginal soft tissue fibrous tumor. Following pathological departmental discussion, the lesion was favored to be a vaginal superficial myofibroblastoma.
The patient had an uneventful postoperative recovery, and telephone follow-up confirmed no evidence of recurrence to date.
This case highlights the essential role of combining TRBU and CEUS in diagnosing indeterminate vaginal masses. The high-resolution imaging of TRBU, complemented by the real-time quantitative microvascular perfusion data from CEUS, allows for a thorough and nuanced evaluation. This combined approach delivers critical insights for accurate diagnosis and subsequent surgical decision-making.